The results have shown some genomic mechanisms contributing to myocardial infarction, whether it be the enrichment of the RAC1 protein leading to the regulation of NADPH oxidase causing heart failure, or the altered regulation in the PP2A gene leading to heart failure and arrhythmia. The gene discussed is FMO5; the disease is cardiac arrhythmia.